human embryo-derived mesenchymal stem cells therapy (Shandong University/The Second Hospital of Shandong University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehuman embryo-derived mesenchymal stem cells therapy (Shandong University/The Second Hospital of Shandong University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShandong University
China Registration ClassN/A

Develop Information

Active CompaniesShandong UniversityThe Second Hospital Of Shandong University
Inactive CompaniesN/A
Active IndicationsDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A